OLMA · Insider trading · 13F holders · Congress trades
Olema Pharmaceuticals Inc (OLMA)
Who is buying and selling OLMA: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 15
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
OLMA at a glance
- No open-market insider purchases or sales of OLMA were filed in the last 90 days.
- 15 13F filers hold OLMA among their 50 largest positions, worth $458.3M combined, including Mark Kingdon. The biggest bets by portfolio weight are Bain Capital Life Sciences Investors, LLC (5.3%), Paradigm Biocapital Advisors LP (2.0%) and Mark Kingdon (2.0%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
- No member of Congress has disclosed a trade in OLMA.
OLMA insider trading
No open-market insider purchases or sales of OLMA were filed in the last 90 days.
Who owns OLMA? Hedge funds and superinvestors
15 13F filers hold OLMA among their 50 largest positions, worth $458.3M combined, including Mark Kingdon. The biggest bets by portfolio weight are Bain Capital Life Sciences Investors, LLC (5.3%), Paradigm Biocapital Advisors LP (2.0%) and Mark Kingdon (2.0%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
Superinvestors holding OLMA: Mark Kingdon 2.0%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LPHedge fund | 2.0% | $108.5M | 8,670,576 | +8.1% shares | Q2 2026 |
| Bain Capital Life Sciences Investors, LLCAsset manager | 5.3% | $88.6M | 7,085,249 | -5.2% shares | Q2 2026 |
| Bvf Inc/ilInvestment manager | 1.7% | $66.3M | 5,295,893 | +0.0% shares | Q2 2026 |
| Siren, L.L.C.Investment manager | 1.2% | $60.8M | 4,856,949 | +2.1% shares | Q2 2026 |
| Logos Global Management LPHedge fund | 1.7% | $40.1M | 3,208,875 | +0.0% shares | Q2 2026 |
| Cormorant Asset Management, LPHedge fund | 1.4% | $26.9M | 2,150,000 | -44.9% shares | Q2 2026 |
| Lightspeed Management Company, L.l.c.Hedge fund | 0.7% | $17.0M | 1,355,299 | +0.0% shares | Q2 2026 |
| Mark KingdonHedge fund | 2.0% | $15.0M | 1,200,000 | +40.4% shares | Q2 2026 |
| Defilade Capital Management, L.P.Hedge fund | 1.5% | $11.6M | 924,758 | -38.5% shares | Q2 2026 |
| Vivo Capital, LLCHedge fund | 0.8% | $8.4M | 671,843 | +0.0% shares | Q2 2026 |
| Jones Hill Capital LPHedge fund | 1.5% | $7.2M | 574,166 | New | Q2 2026 |
| Ikarian Capital, LLCHedge fund | 0.8% | $4.8M | 383,281 | -35.9% shares | Q2 2026 |
| Birchview Capital, LPWealth manager | 1.2% | $2.5M | 199,000 | -9.1% shares | Q2 2026 |
| Portland Investment Counsel Inc.Investment manager | 0.2% | $626K | 50,000 | +0.0% shares | Q2 2026 |
| PSP Research LLCInstitutional asset manager | 0.1% | $86K | 10,000 | — | Q3 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 14). Screen OLMA in the grand portfolio →
OLMA stock trades by members of Congress
No member of Congress has disclosed a trade in OLMA.
OLMA questions and answers
Are insiders buying OLMA stock?
No open-market insider purchases or sales of OLMA were filed in the last 90 days.
Which hedge funds own OLMA?
15 13F filers hold OLMA among their 50 largest positions, worth $458.3M combined, including Mark Kingdon. The biggest bets by portfolio weight are Bain Capital Life Sciences Investors, LLC (5.3%), Paradigm Biocapital Advisors LP (2.0%) and Mark Kingdon (2.0%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
Has Congress traded OLMA?
No member of Congress has disclosed a trade in OLMA.
Who is the largest holder of OLMA?
Among 13F filers, Paradigm Biocapital Advisors LP reports the largest OLMA position, $108.5M (8,670,576 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Bain Capital Life Sciences Investors, LLC's: 5.3% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.